{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:00:15Z","timestamp":1792144815064,"version":"4.4.0"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1001\/jamaoncol.2021.2675","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:55:32Z","timestamp":1625788532000},"page":"1507","source":"Crossref","is-referenced-by-count":126,"title":["Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer"],"prefix":"10.1001","volume":"7","author":[{"given":"Tal","family":"Goshen-Lago","sequence":"first","affiliation":[{"name":"Division of Oncology, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ithai","family":"Waldhorn","sequence":"additional","affiliation":[{"name":"Division of Oncology, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Holland","sequence":"additional","affiliation":[{"name":"Division of Oncology, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Szwarcwort-Cohen","sequence":"additional","affiliation":[{"name":"Virology Laboratory, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Reiner-Benaim","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Shachor-Meyouhas","sequence":"additional","affiliation":[{"name":"General Management, Rambam Health Care Campus, Haifa, Israel"},{"name":"Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khetam","family":"Hussein","sequence":"additional","affiliation":[{"name":"General Management, Rambam Health Care Campus, Haifa, Israel"},{"name":"Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Fahoum","sequence":"additional","affiliation":[{"name":"Division of Oncology, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Baruch","sequence":"additional","affiliation":[{"name":"Division of Oncology, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avivit","family":"Peer","sequence":"additional","affiliation":[{"name":"Division of Oncology, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Reiter","sequence":"additional","affiliation":[{"name":"Technion-Integrated Cancer Center, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Almog","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Halberthal","sequence":"additional","affiliation":[{"name":"General Management, Rambam Health Care Campus, Haifa, Israel"},{"name":"Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Ben-Aharon","sequence":"additional","affiliation":[{"name":"Division of Oncology, Rambam Health Care Campus, Haifa, Israel"},{"name":"Rappaport Faculty of Medicine, Technion, Haifa, Israel"},{"name":"Technion-Integrated Cancer Center, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"coi210040r1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/cncr.v127.9","article-title":"Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta-analysis of cohort studies.","volume":"127","author":"Desai","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"coi210040r2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10241","key":"coi210040r3","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"issue":"20","key":"coi210040r4","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2020.6236","article-title":"Oncology practice during the COVID-19 pandemic.","volume":"323","author":"Schrag","year":"2020","journal-title":"JAMA"},{"issue":"27","key":"coi210040r5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"10264","key":"coi210040r6","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/S0140-6736(20)32224-8","article-title":"Who should be prioritised for COVID-19 vaccines?","volume":"396","author":"Hassan-Smith","year":"2020","journal-title":"Lancet"},{"issue":"15","key":"coi210040r7","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting.","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med"},{"issue":"10277","key":"coi210040r8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(21)00448-7","article-title":"Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.","volume":"397","author":"Amit","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"coi210040r9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1182\/blood.2019004000","article-title":"How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies.","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"issue":"5","key":"coi210040r11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"30","key":"coi210040r12","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.vaccine.2013.04.063","article-title":"Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of anthrax vaccine adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers.","volume":"31","author":"Hopkins","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"coi210040r13","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.4049\/jimmunol.173.3.1663","article-title":"IFN-a subtypes differentially affect human T cell motility.","volume":"173","author":"Foster","year":"2004","journal-title":"J Immunol"},{"issue":"8","key":"coi210040r14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"coi210040r15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41467-019-09652-6","article-title":"Age-specific differences in the dynamics of protective immunity to influenza.","volume":"10","author":"Ranjeva","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"coi210040r16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of responses after SARS-CoV-2 mRNA-1273 vaccination.","volume":"384","author":"Widge","year":"2021","journal-title":"N Engl J Med"},{"issue":"7830","key":"coi210040r17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"issue":"25","key":"coi210040r18","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates.","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"coi210040r19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.7326\/0003-4819-87-5-552","article-title":"Influenza immunization of adult patients with malignant diseases.","volume":"87","author":"Ortbals","year":"1977","journal-title":"Ann Intern Med"},{"issue":"6505","key":"coi210040r20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques.","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"issue":"16","key":"coi210040r21","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.","volume":"383","author":"Corbett","year":"2020","journal-title":"N Engl J Med"},{"issue":"20","key":"coi210040r22","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.2174\/15680266113136660181","article-title":"Immune senescence and vaccination in the elderly.","volume":"13","author":"Lang","year":"2013","journal-title":"Curr Top Med Chem"},{"issue":"25","key":"coi210040r23","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults.","volume":"383","author":"Anderson","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"coi210040r24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12092421","article-title":"The potential role of immune alteration in the cancer\u2013COVID19 equation\u2014a prospective longitudinal study.","volume":"12","author":"Goshen-Lago","year":"2020","journal-title":"Cancers (Basel)"},{"key":"coi210040r10","unstructured":"Department of Laboratories, Ministry of Health, Israel. Protocol for conduction of COVID-19 serology tests. Accessed March 22, 2021. https:\/\/www.gov.il\/BlobFolder\/legalinfo\/bz-306963420-1\/he\/files_publications_corona_bz-477860520.pdf"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2781608\/jamaoncology_goshenlago_2021_oi_210040_1634002307.15009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T16:56:48Z","timestamp":1634835408000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2781608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.2675","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}